The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...

Eli Lilly has received approval in Australia to market its Alzheimer's treatment Kisunla. The pharmaceutical company said Wednesday the Australian Therapeutic Goods Administration granted marketing ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Brain health advocates share tips for detecting Alzheimer’s Disease early, including tests and early signs. Plus, prevention ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are pitted against each other, but only one can be my preferred healthcare stock. Where to invest $1,000 right now? Our analyst team just revealed ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.